Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A genetic marker linked to a type of hair loss was found in most patients studied.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Genetic differences affect COVID-19 severity and treatment effectiveness.

Frontal fibrosing alopecia is linked to four genetic areas, especially the HLA-B*07:02 allele.

Psoriasis patients' immune response to a hair protein depends on their specific gene type.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

Alopecia areata, a common autoimmune hair loss condition, often runs in families.

Researchers found a specific immune receptor in patients that causes severe skin reactions to a drug.

FOXN1 gene mutations cause a rare, severe immune disease treatable with cell or tissue transplants.

Alopecia areata has a complex genetic basis that was not fully understood as of 2001.

Eyebrow follicles are best for accurate genetic testing after stem cell transplants.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

APS-1 in Italy shows diverse AIRE mutations and various autoimmune issues.

Non-immune factors play a significant role in alopecia areata.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

CRPS I is complex, linked to immune and nerve issues, and needs comprehensive treatment.

Recombinant cytokine therapy can cause skin reactions ranging from mild to severe.

Alopecia areata is an autoimmune disease affecting hair follicles and may harm heart health.

Human stem cells have diverse sources and potential uses in medicine.

Vaccines are generally safe, but rare autoimmune reactions can occur, often influenced by genetics.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

More research is needed to understand the genetic causes of Alopecia areata to develop better treatments.

Quercetin effectively treated and prevented hair loss in mice.

Finasteride and minoxidil are effective for hair loss, with potential side effects, and JAK inhibitors show promise for alopecia areata.